Form 4: FRACTYL HEALTH, INC.: Director Amy W. Schulman Reports Purchase of Common Stock

Director Amy W. Schulman reported the purchase of 8,550 shares of FRACTYL HEALTH, INC. common stock at a weighted average price of $1.1654 on March 13, 2025.

Summary

• On March 13, 2025, Amy W. Schulman, a director of FRACTYL HEALTH, INC. (ticker: GUTS), purchased 8,550 shares of common stock.
• The shares were bought at a weighted average price of $1.1654, with individual prices ranging from $1.165 to $1.17.
• Following the transaction, Ms. Schulman directly owns 8,550 shares of FRACTYL HEALTH, INC.
• The purchase was reported on a Form 4 filing with the Securities and Exchange Commission.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares can be seen as a vote of confidence, but the scale of the purchase is relatively small.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's value and future prospects.

Stakeholder Impact

• Shareholders may view the director's stock purchase as a positive signal.

Key Dates